Here we show how G49, an oxyntomodulin (OXM) analog and dual glucagon/glucagon-like peptide-1 receptor (GCGR/GLP-1R) agonist, triggers an inter-organ crosstalk between adipose tissue, pancreas, and liver which is initiated by a rapid release of free fatty acids (FFAs) by white adipose tissue (WAT) in a GCGR-dependent manner
8 Insulin and sulfonylureas If you take insulin or a sulfonylurea (such as gliclazide or glimepiride) for diabetes, starting a weight-loss injection significantly raises your risk of low blood sugar
We explored how the industry is developing next-gen, sustainable, plant-based active nutrition with Bioiberica, Cosun Protein, Gnosis by Lesaffre, HTBA, Lactalis Ingredients, Sensus, and Sirio Europe
Excessive electrolyte supplementation carries real risks
Incidents related to aspiration or regurgitation of gastric contents after appropriate fasting, can be reported to the Canada Vigilance Program at or to ISMP Canada through the Individual Practitioner Reporting portal at The Canadian Medication Incident Reporting and Prevention System (CMIRPS) is a collaborative pan-Canadian program of Health Canada, the Canadian Institute for Health Information (CIHI), the Institute for Safe Medication Practices Canada (ISMP Canada) and Healthcare Excellence Canada (HEC)